APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiovascular Diagnostic Testing

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cardiovascular Diagnostic Testing Industry Growth and Trends Forecast to 2032

4 July 2026100 pages

Choose your research edition.

Industry ResearchCardiovascular Diagnostic Testing Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiovascular Diagnostic Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Cardiovascular Diagnostic Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiovascular Diagnostic Testing Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiovascular Diagnostic Testing Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cardiovascular Diagnostic Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cardiovascular Diagnostic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cardiovascular Diagnostic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cardiovascular Diagnostic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cardiovascular Diagnostic Testing include Abbott Laboratories, BD, bioMérieux, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche, PerkinElmer, Siemens AG and Tosoh Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cardiovascular Diagnostic Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cardiovascular Diagnostic Testing market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cardiovascular Diagnostic Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cardiovascular Diagnostic Testing.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cardiovascular Diagnostic Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cardiovascular Diagnostic Testing Market by Company

Abbott Laboratories

BD

bioMérieux

Bio-Rad Laboratories

Danaher Corporation

F. Hoffmann-La Roche

PerkinElmer

Siemens AG

Tosoh Corporation

Thermo Fisher Scientific

Cardiovascular Diagnostic Testing Segment by Type

Fibrinogen Test

Angiotensin Test

Serum Uric Acid Test

Lipoprotein Test

Cardiovascular Diagnostic Testing Segment by Application

Laboratory Testing Facilities

Point-of-care Testing Facilities

Cardiovascular Diagnostic Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Diagnostic Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Diagnostic Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Diagnostic Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cardiovascular Diagnostic Testing manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cardiovascular Diagnostic Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Fibrinogen Test Table 2. Major Company of Angiotensin Test Table 3. Major Company of Serum Uric Acid Test Table 4. Major Company of Lipoprotein Test Table 5. Global Cardiovascular Diagnostic Testing Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Cardiovascular Diagnostic Testing Sales by Type (2021-2026) & (k units) Table 7. Global Cardiovascular Diagnostic Testing Sales Market Share in Volume by Type (2021-2026) Table 8. Global Cardiovascular Diagnostic Testing Sales by Type (2021-2026) & (US$ Million) Table 9. Global Cardiovascular Diagnostic Testing Sales Market Share in Value by Type (2021-2026) Table 10. Global Cardiovascular Diagnostic Testing Price by Type (2021-2026) & (USD/unit) Table 11. Global Cardiovascular Diagnostic Testing Sales by Type (2027-2032) & (k units) Table 12. Global Cardiovascular Diagnostic Testing Sales Market Share in Volume by Type (2027-2032) Table 13. Global Cardiovascular Diagnostic Testing Sales by Type (2027-2032) & (US$ Million) Table 14. Global Cardiovascular Diagnostic Testing Sales Market Share in Value by Type (2027-2032) Table 15. Global Cardiovascular Diagnostic Testing Price by Type (2027-2032) & (USD/unit) Table 16. North America Cardiovascular Diagnostic Testing Sales by Type (2021-2026) & (k units) Table 17. North America Cardiovascular Diagnostic Testing Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Cardiovascular Diagnostic Testing Sales by Type (2021-2026) & (k units) Table 19. Europe Cardiovascular Diagnostic Testing Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Cardiovascular Diagnostic Testing Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Cardiovascular Diagnostic Testing Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Cardiovascular Diagnostic Testing Sales by Type (2021-2026) & (k units) Table 23. Latin America Cardiovascular Diagnostic Testing Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Cardiovascular Diagnostic Testing Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Cardiovascular Diagnostic Testing Sales by Type (2021-2026) & (US$ Million) Table 26. Cardiovascular Diagnostic Testing Industry Trends Table 27. Cardiovascular Diagnostic Testing Industry Drivers Table 28. Cardiovascular Diagnostic Testing Industry Opportunities and Challenges Table 29. Cardiovascular Diagnostic Testing Industry Restraints Table 30. Global Cardiovascular Diagnostic Testing Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Cardiovascular Diagnostic Testing Revenue Market Share by Company (2021-2026) Table 32. Global Cardiovascular Diagnostic Testing Sales by Company (2021-2026) & (k units) Table 33. Global Cardiovascular Diagnostic Testing Sales Share by Company (2021-2026) Table 34. Global Cardiovascular Diagnostic Testing Market Price by Company (2021-2026) & (USD/unit) Table 35. Global Cardiovascular Diagnostic Testing Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Cardiovascular Diagnostic Testing Major Company Production Sites and Headquarters Table 37. Global Cardiovascular Diagnostic Testing Company, Product Type & Application Table 38. Global Cardiovascular Diagnostic Testing Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Cardiovascular Diagnostic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Cardiovascular Diagnostic Testing Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Cardiovascular Diagnostic Testing Sales by Region (2021-2026) & (k units) Table 43. Global Cardiovascular Diagnostic Testing Sales Market Share in Volume by Region (2021-2026) Table 44. Global Cardiovascular Diagnostic Testing Sales by Region (2021-2026) & (US$ Million) Table 45. Global Cardiovascular Diagnostic Testing Sales Market Share in Value by Region (2021-2026) Table 46. Global Cardiovascular Diagnostic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 47. Global Cardiovascular Diagnostic Testing Sales by Region (2027-2032) & (k units) Table 48. Global Cardiovascular Diagnostic Testing Sales Market Share in Volume by Region (2027-2032) Table 49. Global Cardiovascular Diagnostic Testing Sales by Region (2027-2032) & (US$ Million) Table 50. Global Cardiovascular Diagnostic Testing Sales Market Share in Value by Region (2027-2032) Table 51. Global Cardiovascular Diagnostic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 52. Global Cardiovascular Diagnostic Testing Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Cardiovascular Diagnostic Testing Sales by Application (2021-2026) & (k units) Table 54. Global Cardiovascular Diagnostic Testing Sales Market Share in Volume by Application (2021-2026) Table 55. Global Cardiovascular Diagnostic Testing Sales by Application (2021-2026) & (US$ Million) Table 56. Global Cardiovascular Diagnostic Testing Sales Market Share in Value by Application (2021-2026) Table 57. Global Cardiovascular Diagnostic Testing Price by Application (2021-2026) & (USD/unit) Table 58. Global Cardiovascular Diagnostic Testing Sales by Application (2027-2032) & (k units) Table 59. Global Cardiovascular Diagnostic Testing Sales Market Share in Volume by Application (2027-2032) Table 60. Global Cardiovascular Diagnostic Testing Sales by Application (2027-2032) & (US$ Million) Table 61. Global Cardiovascular Diagnostic Testing Sales Market Share in Value by Application (2027-2032) Table 62. Global Cardiovascular Diagnostic Testing Price by Application (2027-2032) & (USD/unit) Table 63. North America Cardiovascular Diagnostic Testing Sales by Application (2021-2026) & (k units) Table 64. North America Cardiovascular Diagnostic Testing Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Cardiovascular Diagnostic Testing Sales by Application (2021-2026) & (k units) Table 66. Europe Cardiovascular Diagnostic Testing Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Cardiovascular Diagnostic Testing Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Cardiovascular Diagnostic Testing Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Cardiovascular Diagnostic Testing Sales by Application (2021-2026) & (k units) Table 70. Latin America Cardiovascular Diagnostic Testing Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Cardiovascular Diagnostic Testing Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Cardiovascular Diagnostic Testing Sales by Application (2021-2026) & (US$ Million) Table 73. Abbott Laboratories Company Information Table 74. Abbott Laboratories Business Overview Table 75. Abbott Laboratories Cardiovascular Diagnostic Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Abbott Laboratories Cardiovascular Diagnostic Testing Product Portfolio Table 77. Abbott Laboratories Recent Development Table 78. BD Company Information Table 79. BD Business Overview Table 80. BD Cardiovascular Diagnostic Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. BD Cardiovascular Diagnostic Testing Product Portfolio Table 82. BD Recent Development Table 83. bioMérieux Company Information Table 84. bioMérieux Business Overview Table 85. bioMérieux Cardiovascular Diagnostic Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. bioMérieux Cardiovascular Diagnostic Testing Product Portfolio Table 87. bioMérieux Recent Development Table 88. Bio-Rad Laboratories Company Information Table 89. Bio-Rad Laboratories Business Overview Table 90. Bio-Rad Laboratories Cardiovascular Diagnostic Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Bio-Rad Laboratories Cardiovascular Diagnostic Testing Product Portfolio Table 92. Bio-Rad Laboratories Recent Development Table 93. Danaher Corporation Company Information Table 94. Danaher Corporation Business Overview Table 95. Danaher Corporation Cardiovascular Diagnostic Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Danaher Corporation Cardiovascular Diagnostic Testing Product Portfolio Table 97. Danaher Corporation Recent Development Table 98. F. Hoffmann-La Roche Company Information Table 99. F. Hoffmann-La Roche Business Overview Table 100. F. Hoffmann-La Roche Cardiovascular Diagnostic Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. F. Hoffmann-La Roche Cardiovascular Diagnostic Testing Product Portfolio Table 102. F. Hoffmann-La Roche Recent Development Table 103. PerkinElmer Company Information Table 104. PerkinElmer Business Overview Table 105. PerkinElmer Cardiovascular Diagnostic Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. PerkinElmer Cardiovascular Diagnostic Testing Product Portfolio Table 107. PerkinElmer Recent Development Table 108. Siemens AG Company Information Table 109. Siemens AG Business Overview Table 110. Siemens AG Cardiovascular Diagnostic Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Siemens AG Cardiovascular Diagnostic Testing Product Portfolio Table 112. Siemens AG Recent Development Table 113. Tosoh Corporation Company Information Table 114. Tosoh Corporation Business Overview Table 115. Tosoh Corporation Cardiovascular Diagnostic Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Tosoh Corporation Cardiovascular Diagnostic Testing Product Portfolio Table 117. Tosoh Corporation Recent Development Table 118. Thermo Fisher Scientific Company Information Table 119. Thermo Fisher Scientific Business Overview Table 120. Thermo Fisher Scientific Cardiovascular Diagnostic Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Thermo Fisher Scientific Cardiovascular Diagnostic Testing Product Portfolio Table 122. Thermo Fisher Scientific Recent Development Table 123. North America Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. North America Cardiovascular Diagnostic Testing Sales by Country (2021-2026) & (k units) Table 125. North America Cardiovascular Diagnostic Testing Sales Market Share by Country (2021-2026) Table 126. North America Cardiovascular Diagnostic Testing Sales Forecast by Country (2027-2032) & (k units) Table 127. North America Cardiovascular Diagnostic Testing Sales Market Share Forecast by Country (2027-2032) Table 128. North America Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Cardiovascular Diagnostic Testing Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Cardiovascular Diagnostic Testing Market Share by Country (2021-2026) Table 131. North America Cardiovascular Diagnostic Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Cardiovascular Diagnostic Testing Market Share Forecast by Country (2027-2032) Table 133. Europe Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Europe Cardiovascular Diagnostic Testing Sales by Country (2021-2026) & (k units) Table 135. Europe Cardiovascular Diagnostic Testing Sales Market Share by Country (2021-2026) Table 136. Europe Cardiovascular Diagnostic Testing Sales Forecast by Country (2027-2032) & (k units) Table 137. Europe Cardiovascular Diagnostic Testing Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Cardiovascular Diagnostic Testing Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Cardiovascular Diagnostic Testing Market Share by Country (2021-2026) Table 141. Europe Cardiovascular Diagnostic Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Cardiovascular Diagnostic Testing Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Cardiovascular Diagnostic Testing Sales by Country (2021-2026) & (k units) Table 145. Asia-Pacific Cardiovascular Diagnostic Testing Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Cardiovascular Diagnostic Testing Sales Forecast by Country (2027-2032) & (k units) Table 147. Asia-Pacific Cardiovascular Diagnostic Testing Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Cardiovascular Diagnostic Testing Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Cardiovascular Diagnostic Testing Market Share by Country (2021-2026) Table 151. Asia-Pacific Cardiovascular Diagnostic Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Cardiovascular Diagnostic Testing Market Share Forecast by Country (2027-2032) Table 153. Latin America Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. Latin America Cardiovascular Diagnostic Testing Sales by Country (2021-2026) & (k units) Table 155. Latin America Cardiovascular Diagnostic Testing Sales Market Share by Country (2021-2026) Table 156. Latin America Cardiovascular Diagnostic Testing Sales Forecast by Country (2027-2032) & (k units) Table 157. Latin America Cardiovascular Diagnostic Testing Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Cardiovascular Diagnostic Testing Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Cardiovascular Diagnostic Testing Market Share by Country (2021-2026) Table 161. Latin America Cardiovascular Diagnostic Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Cardiovascular Diagnostic Testing Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Cardiovascular Diagnostic Testing Sales by Country (2021-2026) & (k units) Table 165. Middle East and Africa Cardiovascular Diagnostic Testing Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Cardiovascular Diagnostic Testing Sales Forecast by Country (2027-2032) & (k units) Table 167. Middle East and Africa Cardiovascular Diagnostic Testing Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Cardiovascular Diagnostic Testing Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Cardiovascular Diagnostic Testing Market Share by Country (2021-2026) Table 171. Middle East and Africa Cardiovascular Diagnostic Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Cardiovascular Diagnostic Testing Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Cardiovascular Diagnostic Testing Distributors List Table 176. Cardiovascular Diagnostic Testing Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Cardiovascular Diagnostic Testing Image Figure 2. Global Cardiovascular Diagnostic Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiovascular Diagnostic Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Cardiovascular Diagnostic Testing Sales (2021-2032) & (k units) Figure 5. Fibrinogen Test Image Figure 6. Global Fibrinogen Test Sales YoY Growth (2021-2032) & (k units) Figure 7. Angiotensin Test Image Figure 8. Global Angiotensin Test Sales YoY Growth (2021-2032) & (k units) Figure 9. Serum Uric Acid Test Image Figure 10. Global Serum Uric Acid Test Sales YoY Growth (2021-2032) & (k units) Figure 11. Lipoprotein Test Image Figure 12. Global Lipoprotein Test Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Cardiovascular Diagnostic Testing Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Cardiovascular Diagnostic Testing Market Share by Type 2025 VS 2032 Figure 15. North America Cardiovascular Diagnostic Testing Sales Market Share in Volume by Type in 2025 Figure 16. North America Cardiovascular Diagnostic Testing Sales Market Share in Value by Type in 2025 Figure 17. Europe Cardiovascular Diagnostic Testing Sales Market Share in Volume by Type in 2025 Figure 18. Europe Cardiovascular Diagnostic Testing Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Cardiovascular Diagnostic Testing Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Cardiovascular Diagnostic Testing Sales Market Share in Value by Type in 2025 Figure 21. Latin America Cardiovascular Diagnostic Testing Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Cardiovascular Diagnostic Testing Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Cardiovascular Diagnostic Testing Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Cardiovascular Diagnostic Testing Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Cardiovascular Diagnostic Testing Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Laboratory Testing Facilities Image Figure 28. Global Laboratory Testing Facilities Sales YoY Growth (2021-2032) & (k units) Figure 29. Point-of-care Testing Facilities Image Figure 30. Global Point-of-care Testing Facilities Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Cardiovascular Diagnostic Testing Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cardiovascular Diagnostic Testing Market Share by Application 2025 VS 2032 Figure 33. North America Cardiovascular Diagnostic Testing Sales Market Share in Volume by Application in 2025 Figure 34. North America Cardiovascular Diagnostic Testing Sales Market Share in Value by Application in 2025 Figure 35. Europe Cardiovascular Diagnostic Testing Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cardiovascular Diagnostic Testing Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cardiovascular Diagnostic Testing Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cardiovascular Diagnostic Testing Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cardiovascular Diagnostic Testing Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cardiovascular Diagnostic Testing Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cardiovascular Diagnostic Testing Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cardiovascular Diagnostic Testing Sales Market Share in Value by Application in 2025 Figure 43. North America Cardiovascular Diagnostic Testing Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Cardiovascular Diagnostic Testing Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cardiovascular Diagnostic Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cardiovascular Diagnostic Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cardiovascular Diagnostic Testing Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Cardiovascular Diagnostic Testing Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cardiovascular Diagnostic Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cardiovascular Diagnostic Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cardiovascular Diagnostic Testing Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Cardiovascular Diagnostic Testing Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cardiovascular Diagnostic Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cardiovascular Diagnostic Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cardiovascular Diagnostic Testing Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Cardiovascular Diagnostic Testing Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cardiovascular Diagnostic Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cardiovascular Diagnostic Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cardiovascular Diagnostic Testing Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Cardiovascular Diagnostic Testing Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cardiovascular Diagnostic Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cardiovascular Diagnostic Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cardiovascular Diagnostic Testing Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cardiovascular Diagnostic Testing Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Fibrinogen Test
  • Angiotensin Test
  • Serum Uric Acid Test
  • Lipoprotein Test
Applications
  • Laboratory Testing Facilities
  • Point-of-care Testing Facilities
Companies covered
  • Abbott Laboratories
  • BD
  • bioMérieux
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche
  • PerkinElmer
  • Siemens AG
  • Tosoh Corporation
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cardiovascular Diagnostic Testing Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cardiovascular Diagnostic Testing Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cardiovascular Diagnostic Testing Market by Type
  6. 1.3.1 Fibrinogen Test
  7. 1.3.2 Angiotensin Test
  8. 1.3.3 Serum Uric Acid Test
  9. 1.3.4 Lipoprotein Test
  10. 1.4 Global Cardiovascular Diagnostic Testing Market Size by Type
  11. 1.4.1 Global Cardiovascular Diagnostic Testing Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Cardiovascular Diagnostic Testing Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Cardiovascular Diagnostic Testing Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Cardiovascular Diagnostic Testing Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Cardiovascular Diagnostic Testing Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Cardiovascular Diagnostic Testing Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Cardiovascular Diagnostic Testing Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Cardiovascular Diagnostic Testing Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cardiovascular Diagnostic Testing Industry Trends
  2. 2.2 Cardiovascular Diagnostic Testing Industry Drivers
  3. 2.3 Cardiovascular Diagnostic Testing Industry Opportunities and Challenges
  4. 2.4 Cardiovascular Diagnostic Testing Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cardiovascular Diagnostic Testing Revenue (2021-2026)
  2. 3.2 Global Top Players by Cardiovascular Diagnostic Testing Sales (2021-2026)
  3. 3.3 Global Top Players by Cardiovascular Diagnostic Testing Price (2021-2026)
  4. 3.4 Global Cardiovascular Diagnostic Testing Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cardiovascular Diagnostic Testing Major Company Production Sites & Headquarters
  6. 3.6 Global Cardiovascular Diagnostic Testing Company, Product Type & Application
  7. 3.7 Global Cardiovascular Diagnostic Testing Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cardiovascular Diagnostic Testing Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cardiovascular Diagnostic Testing Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cardiovascular Diagnostic Testing Tier 1, Tier 2, and Tier 3
4 Cardiovascular Diagnostic Testing Regional Status and Outlook
  1. 4.1 Global Cardiovascular Diagnostic Testing Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cardiovascular Diagnostic Testing Historic Market Size by Region
  3. 4.2.1 Global Cardiovascular Diagnostic Testing Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cardiovascular Diagnostic Testing Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cardiovascular Diagnostic Testing Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cardiovascular Diagnostic Testing Forecasted Market Size by Region
  7. 4.3.1 Global Cardiovascular Diagnostic Testing Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cardiovascular Diagnostic Testing Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cardiovascular Diagnostic Testing Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cardiovascular Diagnostic Testing by Application
  1. 5.1 Cardiovascular Diagnostic Testing Market by Application
  2. 5.1.1 Laboratory Testing Facilities
  3. 5.1.2 Point-of-care Testing Facilities
  4. 5.2 Global Cardiovascular Diagnostic Testing Market Size by Application
  5. 5.2.1 Global Cardiovascular Diagnostic Testing Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Cardiovascular Diagnostic Testing Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Cardiovascular Diagnostic Testing Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Cardiovascular Diagnostic Testing Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Cardiovascular Diagnostic Testing Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Cardiovascular Diagnostic Testing Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Cardiovascular Diagnostic Testing Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Cardiovascular Diagnostic Testing Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott Laboratories
  2. 6.1.1 Abbott Laboratories Company Information
  3. 6.1.2 Abbott Laboratories Business Overview
  4. 6.1.3 Abbott Laboratories Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Laboratories Cardiovascular Diagnostic Testing Product Portfolio
  6. 6.1.5 Abbott Laboratories Recent Developments
  7. 6.2 BD
  8. 6.2.1 BD Company Information
  9. 6.2.2 BD Business Overview
  10. 6.2.3 BD Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 BD Cardiovascular Diagnostic Testing Product Portfolio
  12. 6.2.5 BD Recent Developments
  13. 6.3 bioMérieux
  14. 6.3.1 bioMérieux Company Information
  15. 6.3.2 bioMérieux Business Overview
  16. 6.3.3 bioMérieux Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 bioMérieux Cardiovascular Diagnostic Testing Product Portfolio
  18. 6.3.5 bioMérieux Recent Developments
  19. 6.4 Bio-Rad Laboratories
  20. 6.4.1 Bio-Rad Laboratories Company Information
  21. 6.4.2 Bio-Rad Laboratories Business Overview
  22. 6.4.3 Bio-Rad Laboratories Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bio-Rad Laboratories Cardiovascular Diagnostic Testing Product Portfolio
  24. 6.4.5 Bio-Rad Laboratories Recent Developments
  25. 6.5 Danaher Corporation
  26. 6.5.1 Danaher Corporation Company Information
  27. 6.5.2 Danaher Corporation Business Overview
  28. 6.5.3 Danaher Corporation Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Danaher Corporation Cardiovascular Diagnostic Testing Product Portfolio
  30. 6.5.5 Danaher Corporation Recent Developments
  31. 6.6 F. Hoffmann-La Roche
  32. 6.6.1 F. Hoffmann-La Roche Company Information
  33. 6.6.2 F. Hoffmann-La Roche Business Overview
  34. 6.6.3 F. Hoffmann-La Roche Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 F. Hoffmann-La Roche Cardiovascular Diagnostic Testing Product Portfolio
  36. 6.6.5 F. Hoffmann-La Roche Recent Developments
  37. 6.7 PerkinElmer
  38. 6.7.1 PerkinElmer Company Information
  39. 6.7.2 PerkinElmer Business Overview
  40. 6.7.3 PerkinElmer Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 PerkinElmer Cardiovascular Diagnostic Testing Product Portfolio
  42. 6.7.5 PerkinElmer Recent Developments
  43. 6.8 Siemens AG
  44. 6.8.1 Siemens AG Company Information
  45. 6.8.2 Siemens AG Business Overview
  46. 6.8.3 Siemens AG Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Siemens AG Cardiovascular Diagnostic Testing Product Portfolio
  48. 6.8.5 Siemens AG Recent Developments
  49. 6.9 Tosoh Corporation
  50. 6.9.1 Tosoh Corporation Company Information
  51. 6.9.2 Tosoh Corporation Business Overview
  52. 6.9.3 Tosoh Corporation Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Tosoh Corporation Cardiovascular Diagnostic Testing Product Portfolio
  54. 6.9.5 Tosoh Corporation Recent Developments
  55. 6.10 Thermo Fisher Scientific
  56. 6.10.1 Thermo Fisher Scientific Company Information
  57. 6.10.2 Thermo Fisher Scientific Business Overview
  58. 6.10.3 Thermo Fisher Scientific Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Thermo Fisher Scientific Cardiovascular Diagnostic Testing Product Portfolio
  60. 6.10.5 Thermo Fisher Scientific Recent Developments
7 North America by Country
  1. 7.1 North America Cardiovascular Diagnostic Testing Sales by Country
  2. 7.1.1 North America Cardiovascular Diagnostic Testing Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cardiovascular Diagnostic Testing Sales by Country (2021-2026)
  4. 7.1.3 North America Cardiovascular Diagnostic Testing Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cardiovascular Diagnostic Testing Market Size by Country
  6. 7.2.1 North America Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cardiovascular Diagnostic Testing Market Size by Country (2021-2026)
  8. 7.2.3 North America Cardiovascular Diagnostic Testing Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cardiovascular Diagnostic Testing Sales by Country
  2. 8.1.1 Europe Cardiovascular Diagnostic Testing Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cardiovascular Diagnostic Testing Sales by Country (2021-2026)
  4. 8.1.3 Europe Cardiovascular Diagnostic Testing Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cardiovascular Diagnostic Testing Market Size by Country
  6. 8.2.1 Europe Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cardiovascular Diagnostic Testing Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cardiovascular Diagnostic Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cardiovascular Diagnostic Testing Sales by Country
  2. 9.1.1 Asia-Pacific Cardiovascular Diagnostic Testing Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cardiovascular Diagnostic Testing Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cardiovascular Diagnostic Testing Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cardiovascular Diagnostic Testing Market Size by Country
  6. 9.2.1 Asia-Pacific Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cardiovascular Diagnostic Testing Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cardiovascular Diagnostic Testing Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cardiovascular Diagnostic Testing Sales by Country
  2. 10.1.1 South America Cardiovascular Diagnostic Testing Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cardiovascular Diagnostic Testing Sales by Country (2021-2026)
  4. 10.1.3 South America Cardiovascular Diagnostic Testing Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cardiovascular Diagnostic Testing Market Size by Country
  6. 10.2.1 South America Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cardiovascular Diagnostic Testing Market Size by Country (2021-2026)
  8. 10.2.3 South America Cardiovascular Diagnostic Testing Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cardiovascular Diagnostic Testing Sales by Country
  2. 11.1.1 Middle East and Africa Cardiovascular Diagnostic Testing Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cardiovascular Diagnostic Testing Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cardiovascular Diagnostic Testing Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cardiovascular Diagnostic Testing Market Size by Country
  6. 11.2.1 Middle East and Africa Cardiovascular Diagnostic Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cardiovascular Diagnostic Testing Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cardiovascular Diagnostic Testing Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cardiovascular Diagnostic Testing Value Chain Analysis
  2. 12.1.1 Cardiovascular Diagnostic Testing Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cardiovascular Diagnostic Testing Production Mode & Process
  7. 12.2 Cardiovascular Diagnostic Testing Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cardiovascular Diagnostic Testing Distributors
  10. 12.2.3 Cardiovascular Diagnostic Testing Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst